Your browser doesn't support javascript.
loading
Susceptibility of Lung Carcinoma Cells to Nanostructured Lipid Carrier of ARV-825, a BRD4 Degrading Proteolysis Targeting Chimera.
Vartak, Richa; Saraswat, Aishwarya; Yang, Yuqi; Chen, Zhe-Sheng; Patel, Ketan.
Affiliation
  • Vartak R; Department of Pharmaceutical Sciences, College of Pharmacy and Health Sciences, St. Albert Hall, B49, St. John's University, 8000 Utopia Parkway, Queens, New York, 11439, USA.
  • Saraswat A; Department of Pharmaceutical Sciences, College of Pharmacy and Health Sciences, St. Albert Hall, B49, St. John's University, 8000 Utopia Parkway, Queens, New York, 11439, USA.
  • Yang Y; Department of Pharmaceutical Sciences, College of Pharmacy and Health Sciences, St. Albert Hall, B49, St. John's University, 8000 Utopia Parkway, Queens, New York, 11439, USA.
  • Chen ZS; Department of Pharmaceutical Sciences, College of Pharmacy and Health Sciences, St. Albert Hall, B49, St. John's University, 8000 Utopia Parkway, Queens, New York, 11439, USA.
  • Patel K; Department of Pharmaceutical Sciences, College of Pharmacy and Health Sciences, St. Albert Hall, B49, St. John's University, 8000 Utopia Parkway, Queens, New York, 11439, USA. patelk2@stjohns.edu.
Pharm Res ; 39(11): 2745-2759, 2022 Nov.
Article in En | MEDLINE | ID: mdl-35146591

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Carcinoma / Carcinoma, Non-Small-Cell Lung / Nanostructures / Lung Neoplasms Type of study: Prognostic_studies Limits: Humans Language: En Journal: Pharm Res Year: 2022 Document type: Article Affiliation country: Country of publication:

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Carcinoma / Carcinoma, Non-Small-Cell Lung / Nanostructures / Lung Neoplasms Type of study: Prognostic_studies Limits: Humans Language: En Journal: Pharm Res Year: 2022 Document type: Article Affiliation country: Country of publication: